Last reviewed · How we verify
NCT05352984: Postponement
Postponement Rate of Elective Surgical Procedures
trial in Surgical Procedure in 1,221 participants. Completed in 15 February 2023.
19 August 2022
Quick facts
| Lead sponsor | Hayatabad Medical Complex |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,221 |
| Start date | 19 May 2022 |
| Primary completion | 19 August 2022 |
| Estimated completion | 15 February 2023 |
| Sites | 1 location across Pakistan |
Conditions studied
- Surgical Procedure — all drugs for Surgical Procedure →
Sponsor
Hayatabad Medical Complex — full company profile →
Who can join
15 and older, any sex, with Surgical Procedure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Postponement of elective surgical procedures is a major issue in health care facilities. It increases burden on hospitals and healthcare systems as well as misery of the patients and their family members. Patient's stay in the hospitals is prolonged. Hospitals and patients resources are wasted and their expenses are increased. The rate of postponement is different in different regions. It is estimated to be in between 9 to 44 %. Reason may be organizational or medical. Elective procedures are cancelled due to insufficient OT timings, non-availability of; anesthetists, blood or beds in ICU, change of plan and medical reasons like respiratory infections, cardiac problems, hypertension and uncontrolled diabetes. Tertiary care hospitals in Peshawar, Khyber Pakhtunkhwa, Pakistan are overburdened and patients on OT list are frequently postponed. Operating room timings has been increased to overcome the issue but no recent data is available regarding actual postponement rate and possible causes in this region. The need is felt to assess the problem and suggest recommendations to decrease patients' sufferings and improve hospital workings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05352984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hayatabad Medical Complex trials
Trials by the same sponsor.
- NCT07522788 — Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma · Phase 4 · not yet recruiting
- NCT07422558 — Intravenous Nalbuphine Versus Lidocaine for Prevention of Propofol Injection Pain · NA · not yet recruiting
- NCT07460050 — Comparison of Two Sedative Agents in Terms of Controlled Hypotension · NA · not yet recruiting
- NCT07233382 — Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies · NA · not yet recruiting
- NCT07451990 — Comparison of Vicryl Versus Prolene for Midline Rectus Sheath Closure After Elective Laparotomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05352984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hayatabad Medical Complex
- Last refreshed: 14 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05352984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing